Help us improve Portfolio Grader.

Help us improve Portfolio Grader.

Blue Chip Growth

Stock Report: "Pernix Therapeutics Holdings, Inc." (PTX) Report Updated: Feb 08, 2016 | Print This Page

Get more stock ratings by Louis Navellier

"Pernix Therapeutics Holdings, Inc." (PTX)

Rating: Sell Volatility: Moderate
Total Grade: D Industry: Pharmaceuticals
Competitors: HSKA, JNP, AXN, SUPN

Stock Analysis

Rating: Monthly View

February March April May June July August September October November December January

Rating: Weekly View

This Week: D down no change
Last Week: D same no change
Two Weeks Ago: D up no change
service keys

"Pernix Therapeutics Holdings, Inc."© quotemedia

Company Profile

Pernix Therapeutics Holdings, Inc., a pharmaceutical company, focuses on developing, marketing, and selling branded and generic pharmaceutical products for pediatric and adult indications in various therapeutic areas. Its products comprise ALDEX, an antihistamines, decongestants, and cough suppressants for the temporary relief of respiratory allergies, allergic rhinitis, and symptoms of common cold; BROVEX, an antihistamine for the temporary relief of sneezing, itchy, watery eyes, itchy nose or throat, and runny nose due to hay fever or other respiratory allergies; and CEDAX, a oral cephalosporin used for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza, or streptococcus pyogenes. The company also offers NATROBA, a prescription medicine used to treat head lice in adults and children; PEDIATEX, an antihistamine/nasal decongestant liquid for oral administration; and REZYST, a proprietary probiotic blend that promotes the dietary management of patients with the distinctive nutritional requirements associated with the gastro-intestinal flora. In addition, it engages in the development of Theobromine, an alkaloid for persistent cough. The company serves drug wholesalers, retail drug stores, mass merchandisers, and grocery store pharmacies in the United States. Pernix Therapeutics Holdings, Inc. was founded in 1996 and is headquartered in The Woodlands, Texas.

Recent News: "Pernix Therapeutics Holdings, Inc."